Clinical Trials Browser

Phase 2/3 × Recruiting × Decitabine × Clear all

NCT03793517 2020-03-10

Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT

Phase 2/3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute